FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conrad, K. P.
Right arrow Articles by Miles, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conrad, K. P.
Right arrow Articles by Miles, T. M.

The FASEB Journal, Vol 10, 760-768, Copyright © 1996 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Expression of erythropoietin by the human placenta

KP Conrad, DF Benyo, A Westerhausen-Larsen and TM Miles
Magee-Womens Research Institute, Pittsburgh, Pennsylvania 15213, USA.

Circulating levels of maternal erythropoietin (EPO) rise during gestation due to increased biosynthesis of the hormone. Our objective was to investigate the human placenta as a potential extrarenal site of EPO production. Using two monoclonal antibodies recognizing different antigenic determinants, we identified immunoreactive EPO associated with villous cytotrophoblast, endovascular and intravascular cytotrophoblast, cytotrophoblast cell columns, and syncytiotrophoblast of first and second-trimester placenta as well as syncytiotrophoblast and extravillous cytotrophoblast of normal third-trimester and preeclamptic placenta. In addition, cultured JAR (trophoblast-derived) choriocarcinoma cells, cytotrophoblasts isolated from term placenta, villous core cells, and possibly other nontrophoblast cells within the decidual basal plate expressed immunoreactive EPO. Using reverse transcription-polymerase chain reaction and EPO-specific primers, a 378 bp DNA product was amplified from placental tissues of various gestational ages, cytotrophoblasts isolated from term placenta, and JAR choriocarcinoma cells. The amplified product yielded restriction enzyme fragments of predicted sizes. On Southern analysis, hybridization was observed for two of these fragments in which the radiolabeled EPO cDNA probe did not overlap with the primer sequences. Finally, the JAR choriocarcinoma cells elaborated EPO into the culture medium as determined by enzyme-linked immunosorbant assay and expressed EPO mRNA as determined by Northern analysis, both of which were stimulated by hypoxia (15-20 torr). Taken together, these results suggest a new site of EPO expression: the trophoblast cell of the human placenta.


This article has been cited by other articles:


Home page
BloodHome page
N. Paffett-Lugassy, N. Hsia, P. G. Fraenkel, B. Paw, I. Leshinsky, B. Barut, N. Bahary, J. Caro, R. Handin, and L. I. Zon
Functional conservation of erythropoietin signaling in zebrafish
Blood, October 1, 2007; 110(7): 2718 - 2726.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts
Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. E. Hardee, M. O. Arcasoy, K. L. Blackwell, J. P. Kirkpatrick, and M. W. Dewhirst
Erythropoietin Biology in Cancer
Clin. Cancer Res., January 15, 2006; 12(2): 332 - 339.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Sairanen, M.-L. Karjalainen-Lindsberg, A. Paetau, P. Ijas, and P. J. Lindsberg
Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments
Brain, January 1, 2006; 129(1): 189 - 199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. M. Kumar, G. Acs, D. Fang, M. Herlyn, D. E. Elder, and X. Xu
Functional Erythropoietin Autocrine Loop in Melanoma
Am. J. Pathol., March 1, 2005; 166(3): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Fandrey
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R977 - R988.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. J Smith, A. J Bleyer, W. C Little, and D. C Sane
The cardiovascular effects of erythropoietin
Cardiovasc Res, September 1, 2003; 59(3): 538 - 548.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Matsuzaki, M. Canis, R. Yokomizo, N. Yaegashi, M. A. Bruhat, and K. Okamura
Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis
Hum. Reprod., January 1, 2003; 18(1): 152 - 166.
[Abstract] [Full Text] [PDF]


Home page
J Hum LactHome page
R. D. Semba and S. E. Juul
Erythropoietin in Human Milk: Physiology and Role in Infant Health
J Hum Lact, August 1, 2002; 18(3): 252 - 261.
[Abstract] [PDF]


Home page
Mol Hum ReprodHome page
R. Yokomizo, S. Matsuzaki, S. Uehara, T. Murakami, N. Yaegashi, and K. Okamura
Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle
Mol. Hum. Reprod., May 1, 2002; 8(5): 441 - 446.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Magnanti, O. Gandini, L. Giuliani, P. Gazzaniga, H. H. Marti, A. Gradilone, L. Frati, A. M. Agliano, and M. Gassmann
Erythropoietin expression in primary rat Sertoli and peritubular myoid cells
Blood, November 1, 2001; 98(9): 2872 - 2874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. D. Sohl, C. Y. Cheung, J. A. Widness, and R. A. Brace
Erythropoietin responses to progressive blood loss over 10 days in the ovine fetus
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1051 - R1058.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Matsuzaki, T. Murakami, S. Uehara, R. Yokomizo, T. Noda, Y. Kimura, and K. Okamura
Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis
Hum. Reprod., May 1, 2001; 16(5): 945 - 948.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
P. VUORELA, S. HELSKE, C. HORNIG, K. ALITALO, H. WEICH, and E. HALMESMAKI
Amniotic Fluid-Soluble Vascular Endothelial Growth Factor Receptor-1 in Preeclampsia
Obstet. Gynecol., March 1, 2000; 95(3): 353 - 357.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Fairchild Benyo and K. P. Conrad
Expression of the Erythropoietin Receptor by Trophoblast Cellsin the Human Placenta
Biol Reprod, April 1, 1999; 60(4): 861 - 870.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. Fried, R. O. Muga, A. O. Misore, and P. E. Duffy
Malaria Elicits Type 1 Cytokines in the Human Placenta: IFN-{gamma} and TNF-{alpha} Associated with Pregnancy Outcomes
J. Immunol., March 1, 1998; 160(5): 2523 - 2530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. M. Moritz, G. B. Lim, and E. M. Wintour
Developmental regulation of erythropoietin and erythropoiesis
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1829 - R1844.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. F. Benyo, T. M. Miles, and K. P. Conrad
Hypoxia Stimulates Cytokine Production by Villous Explants from the Human Placenta
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1582 - 1588.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The Federation of American Societies for Experimental Biology.